š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This double-blind 8 week study will evaluate dose response, efficacy (blood...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-06
Trial ID
NCT01150357
Treatments Being Tested
After a wash-out (1 to 2 weeks), and 2 to 4 week single-blind placebo run-i...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-04
Trial ID
NCT00219167
Treatments Being Tested
This study will evaluate the efficacy and safety of aliskiren 75 mg, 150 mg...
Status
Completed
Location
Investigative Site
Start Date
2008-05
Trial ID
NCT00706134
Treatments Being Tested
The core and extension studies assessed the safety and efficacy of aliskire...
Status
Completed
Location
Novartis US
Start Date
2006-12
Trial ID
NCT00414609
This study will assess the bioavailability of aliskiren and valsartan as a ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-11
Trial ID
NCT00416468
This study is designed to investigate the efficacy, safety and tolerability...
Status
Completed
Location
Novartis Investigative Sites
Start Date
2007-09
Trial ID
NCT00529451
This is a study for people diagnosed with hypertension to compare 3 doses (...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-11
Trial ID
NCT00260923
Treatments Being Tested
The purpose of this study is to test the hypothesis that the inhibition of ...
Status
Completed
Location
Investigative Site
Start Date
2007-02
Trial ID
NCT00409578
Treatments Being Tested
The purpose of this study is to evaluate in a randomized, double-blind fash...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-08
Trial ID
NCT01151410
The purpose of this study is to evaluate the safety and efficacy of the blo...
Status
Terminated
Location
University of Colorado Denver
Start Date
2011-05
Trial ID
NCT01235910
Treatments Being Tested